Serum Institute claims, up to 300 million doses of Corona vaccine for country by December | Serum Institute claims, up to 300 million doses of Corona vaccine for country by December

AdvertisementAmazon Great Indian Sale Banner
  • Hindi news
  • National
  • Serum Institute Claims, Up To 300 Million Doses Of Corona Vaccine For Country By December

new Delhi22 minutes ago

  • Copy link

File photo

The Serum Institute (SSI) said it would make 300 million doses of the Corona vaccine by December. The Institute’s Executive Director, Dr. Suresh Jadhav said that the vaccines will be launched as soon as the license is received from DCGI. The Serum Institute collaborates with Oxford University and AstraZeneca to produce the vaccine. Dr. Jadhav said that the serum is working on 5 different products. Of the dosas that will be made, half will be sent to India and half to Milinda-Bill Gates’ organization Gavi to help the poor countries.

Recommendation of trial of Russian vaccine: The Expert Committee of CDSCO has recommended the second phase trial of Russian vaccine Sputnik-5 in India. Approval can be given in two days.

When will the vaccine be received?

Dr. Jadhav said- We will make the data of Phase III trial available to the regulator DCGI in December. If the regulators are satisfied, then we can get a license for emergency use of the vaccine in a month with marketing authority. Then we will go to WHO for prequalification. Vaccines will then enter the market.

Who will get it first?

Serum said- Health workers should be first on the priority list for vaccination. The second number is the elderly above 60 years. Those under 18 years of age are undergoing very few tests, so it may be that their numbers will come later. Citizens between 18 and 50 years of age can be vaccinated in the vaccine.

This situation now: Trials of four companies are going on, the only serum in the third phase

  • The Phase III trial of the Serum Institute Oxford vaccine is underway. Trial results may come in December.
  • Bharat Biotech Phase II trial is underway. The second phase of the trial will be completed this month. Then there will be a third phase trial.
  • Zydus Cadila is in preparation for the second phase of the trial.
  • Biological-E has previously received approval for phase-in clinical trials. Similarly, Dr. Reddy Laboratories is in preparation for the second phase of the Russian vaccine trial. Approval is yet to be received.

Haryana – Nearly 1.5 lakh infected figures reached

1177 new patients are found in Haryana in a day. 6 patients have died. One new death occurred each in Karnal, Panchkula, Panipat, Bhiwani, Fatehabad and Sirsa. Now the figure of total deaths has been 1693. While the number of infected has been 1,49,435. 1318 patients have recovered in 24 hours. 137,176 patients have become healthy so far. 10,566 patients are undergoing treatment. The condition of 195 is serious. There are 14 districts in the state where more than 90% patients have been cured. The state’s average recovery rate is 91.79 percent.

Deaths exceed 4 thousand in Punjab, 8th state where maximum deaths, 452 new cases

The death toll in Corona epidemic in Punjab has crossed 4 thousand. On Saturday, 22 new deaths occurred and 453 people were infected. However, 760 patients returned during the day recovering. The total infectious population now stands at 1,27367. Of these, 1,16925 patients have been cured. At the same time, the total number of dead has now reached 4007. Punjab ranks 8th in the country in terms of more than 4 thousand deaths. There are 6152 active patients in the state. Of these, 144 are on oxygen support and 22 on ventilators.

AdvertisementAmazon Great Indian Sale Banner


Please enter your comment!
Please enter your name here